Can China’s JBM Healthcare Sustain Its 70% Dividend Payout?

Shares of the over-the-counter traditional Chinese medicine company tumbled after it reported sequential revenue and profit declines in the second half of its fiscal year image credit: Bamboo Works Key Takeaways: JBM Healthcare’s profit edged up 1.9% in its latest fiscal year through March The over-the-counter traditional Chinese medicine company’s full-year dividend payout ratio reached a generous 70%. It’s safe to say that most ordinary consumers have never heard of JBM (Healthcare) Ltd. (2161.HK). But the brands from its proprietary cabinet of over-the-counter (OTC) traditional Chinese medicines (TCM), like Po Chai Pills, Ho Chai Kung, Flying Eagle Woodlok Medicated Oil,…